Aprameya EngineeringNSE:APRAMEYA -0.54%42 Net Current Asset Value is ₹31.74 as of Mar. 2026, which is 100% below its 10-year median of 4.93. GuruFocus rates NSE:APRAMEYA with a GF Score™ of 42/100. The stock has 6 warning signs investors should review. Among 569 Medical Devices & Instruments companies, Aprameya Engineering ranks better than 53.78% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Aprameya Engineering's net current asset value per share for the quarter that ended in Mar. 2026 was ₹31.74.
The historical rank and industry rank for Aprameya Engineering's Net Current Asset Value or its related term are showing as below:
NSE:APRAMEYA'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 3.44 Med: 4.93 Max: 6.42
Current: 4.6
During the past 7 years, the highest Price-to-Net-Current-Asset-Value Ratio of Aprameya Engineering was 6.42. The lowest was 3.44. And the median was 4.93.
NSE:APRAMEYA's Price-to-Net-Current-Asset-Value is ranked better than 53.78% of 569
companies
in the Medical Devices & Instruments industry
Industry Median: 4.99
vs NSE:APRAMEYA: 4.60
Aprameya Engineering (NSE:APRAMEYA) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Aprameya Engineering Net Current Asset Value Related Terms
Aprameya Engineering Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Aprameya Engineering's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aprameya Engineering Net Current Asset Value Chart
NSE:APRAMEYA vs ISRG, BDX, MDLN: Net Current Asset Value Comparison
For the Medical Instruments & Supplies subindustry, Aprameya Engineering's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aprameya Engineering Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aprameya Engineering's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Aprameya Engineering's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of ₹31.74 mean?
Aprameya Engineering (NSE:APRAMEYA) has a Net Current Asset Value of ₹31.74 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Aprameya Engineering and its competitors. This is 544% above median its historical median of 4.93. Over the past decade, Aprameya Engineering's Net Current Asset Value has ranged from 3.44 to 6.42. According to the industry distribution chart, Aprameya Engineering ranks #263 out of 569 companies in the Medical Devices & Instruments industry, placing it in the top 46.2%.
Is Aprameya Engineering's Net Current Asset Value too high?
Aprameya Engineering's current Net Current Asset Value of ₹31.74 is 544% above median its 10-year median of 4.93. Over the past 10 years, this metric has ranged from a low of 3.44 to a high of 6.42. Based on the distribution chart, Aprameya Engineering ranks #263 out of 569 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Aprameya Engineering has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Aprameya Engineering's Net Current Asset Value compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Aprameya Engineering ranks #263 out of 569 companies for Net Current Asset Value. This puts Aprameya Engineering in the upper half of its industry. The industry median Net Current Asset Value is 4.99. Historically, Aprameya Engineering's own Net Current Asset Value has ranged from 3.44 to 6.42 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 4.99, based on 569 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Aprameya Engineering and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 4.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aprameya Engineering's current Net Current Asset Value is ₹31.74, which is 544% above median its own 10-year median of 4.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprameya Engineering stock overvalued right now?
Aprameya Engineering (NSE:APRAMEYA) has a current Net Current Asset Value of ₹31.74. The current Net Current Asset Value is ₹31.74, which is 544% above median its 10-year median of 4.93. Aprameya Engineering's overall GF Score™ is 42/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Aprameya Engineering (NSE:APRAMEYA), the current Net Current Asset Value is ₹31.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aprameya Engineering Ltd is engaged in the business of installation, set up & maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatre, dialysis centres and prefabricated structure ward (hereinafter referred to as Healthcare Infrastructure projects) in the hospitals and medical care centers on turnkey basis with the supply of high-value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals, and medical practitioners. The company has two Business segments: Trading of Medical support Equipment (Trading Sales) and Supplies for Infra Projects for health care sectors (Turnkey project supplies). Key revenue is generated from Trunkey Project Supply.
42GF Score
Get the complete analysis for NSE:APRAMEYA
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:APRAMEYA has been successfully added to your 
